• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Celgene elects Mark Alles and Jacqualyn Fouse

Celgene elects Mark Alles and Jacqualyn Fouse

February 12, 2016
CenterWatch Staff

Celgene has elected Mark Alles and Jacqualyn Fouse, Ph.D., to its Board of Directors.

Effective March 1, Alles will be promoted to chief executive officer, with Bob Hugin assuming the executive chairman role. Also effective March 1, Fouse will be promoted to President and COO.

Alles has been with Celgene since 2004, most recently serving as president and chief operating officer (COO). Before serving as president and COO, Alles led Celgene's Hematology and Oncology franchise.

Fouse has been with Celgene since 2010, most recently serving as president of Celgene's Hematology and Oncology franchise. Before serving as president of Celgene's Hematology and Oncology franchise, Dr. Fouse served as Celgene's chief financial officer.

"Mark and Jackie are extremely accomplished leaders who bring a wealth of experience and judgment to our Board," said Bob Hugin, chairman and CEO of Celgene. "Their strategic vision and knowledge of our business will be highly valued as we continue to guide Celgene's future."

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing